LightOx Ltd
PrivateLast Round
Grant
Aug 1, 2024
Total Funding Raised
$3.42M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
LightOx Ltd operates in Healthcare & Life Sciences and is based in Newcastle upon Tyne. Its latest recorded funding round was a Grant round in August 2024.
LightOx Ltd is a drug discovery company developing a new class of light-activated chemotherapy for the treatment of early-stage oral cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Imaging, Precision Medicine
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
LightOx Ltd Comparables
Compare LightOx Ltd with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Light Switch Bio | 81% | |
| Illuminate Therapeutics | 79% | |
| Rakuten Medical | 79% |
For institutional investors. Book with your work email.
LightOx Ltd Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 1, 2024 | ||||
| VC Round | Jun 13, 2024 | ||||
| Grant | Jun 6, 2023 | ||||
| Grant | Jan 30, 2023 | ||||
| Seed | Oct 13, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
LightOx Ltd Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| Praetura Ventures | VC Round |
| NG Bio | Seed |
| Innovate UK | Grant |
| Meneldor | Seed |
| Northstar Ventures | VC Round, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 46% MoM.
- May 15, 2026
Monthly visitors increased 138% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingOct 20, 2026
LIGHTOX Ltd is developing light-activated antimicrobial technology for wound care, including a spray-based approach that generates bacteria-killing reactive oxygen species when exposed to light, on Oct 20th '26.
For institutional investors. Book with your work email.
LightOx Ltd Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about LightOx Ltd's valuation, stock price, and market status.
Is LightOx Ltd a public or private company?
LightOx Ltd is a private company.
What is the current stock price of LightOx Ltd?
LightOx Ltd is a private company, so its shares have no public market price. Caplight tracks LightOx Ltd's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is LightOx Ltd worth (valuation)?
Valuation information for LightOx Ltd is not publicly available.
Can I buy LightOx Ltd stock?
LightOx Ltd shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was LightOx Ltd's last funding round?
LightOx Ltd's most recent funding round was Grant on August 1, 2024.
Who are the main investors in LightOx Ltd?
Key investors in LightOx Ltd include Innovate UK, Praetura Ventures, Northstar Ventures.
Will LightOx Ltd IPO soon?
No public IPO plans have been announced for LightOx Ltd.
How can I track LightOx Ltd secondary market activity?
Caplight tracks bids, offers, and trades in LightOx Ltd's shares on secondary markets.